GL1X · GenesisL1 explorer

Research workbench

Counteracting HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with XV638 and SD146, cyclic urea amides with broad specificities

Analyse Counteracting HIV-1 protease drug resistance: structural analysis of mutant… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1BV7
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein (HIV-1 protease)
EC
3.4.23.16
UniProt
P04585
Ligands
XV6
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtein (HIV-1 protease) (EC 3.4.23.16)protein994% helix, 55% strandP04585

Ligands and binding sites

  • XV6 · [4R-(4alpha,5alpha,6beta,7beta)]-3,3'-[[tetrahydro-5,6-dihydroxy-2-oxo-4,7-bis(phenylmethyl)-1H-1,3-diazepine-1,3(2H)-D iyl] bis(methylene)]bis[n-2-thiazolylbenzamide] · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13780.710.8233XV6

Interfaces

1 interface between chains.

  • A–B · 1842 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 1BV7 · Counteracting HIV-1 protease drug resistance: structural analysis of mutant proteases… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.